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Summary Study of the distribution of the p21 ras oncogene product as demonstrated by monoclonal
antibody Y13-259 shows this protein to be apparently present in all epithelial populations of both
premalignant and malignant tumours and throughout the normal foetal and adult epithelial crypt population
in the colorectum. Metastatic tumour in liver shows a similar staining pattern which is less intense however
than in the surrounding normal hepatocytes. Our results suggest that the presence of this protein is a
widespread feature of normal cellular metabolism in certain cell types and is not restricted to those actively
involved in cellular proliferation. It appears, furthermore, that neither cells at different stages of
carcinogenesis nor those representing variants of a malignant phenotype can be identified using this particular
antibody.
The ras family of oncogenes is one of a group of
cellular oncogenes initially identified by virtue of
their homology to sequences present in acutely
transforming oncogenic retroviruses (Bishop, 1983).
Several such oncogenes have been identified as the
transforming genes in biological transfection assays,
and abnormal oncogene activity at either a
qualitative or quantitative level has been shown in a
variety of human tumours (Cooper, 1984).
Activation of members of the ras family of
oncogenes (comprising Kirsten, Harvey and N-ras)
has been demonstrated in a variety of tumours
including carcinomas (eg lung, colon, bladder),
tumours of neural origin (eg melanoma, neuro-
blastoma) as well as in certain lymphoid neoplasia
(for a review see Balmain, 1985). In some of these
cases activation appears to be associated with
mutations most commonly involving 'hot spots'
around codons 12 and 61. The exact significance of
ras oncogene activity in carcinogenesis or the
stage(s) at which this may be critical remains,
however, far from clear. Although active trans-
forming ras genes were initially identified in frankly
malignant tumours we have demonstrated activated
Ha-ras in carcinogen induced premalignant mouse
skin papillomas (Balmain et al., 1984) and we have
also shown elevated expression of ras family
oncogenes in pre-malignant as well as in malignant
tumours of the colorectum (Spandidos & Kerr,
1984).
Similarly, little is known of the physiological role
of the ras oncogene p21 protein products. They are
known to comprise a family of proteins of Mol.
Wt. 21-24 kilodaltons and to be located on the
cytoplasmic side of the cell membrane (Willingham
et al., 1980). They possess GTP-binding (Shih et al.,
1979) and GTP-ase (Sweet et al., 1984) activity and
show homology with the 'G' protein which
regulates hormone sensitive adenylate cyclase
activity (Gilman, 1984). GTP dependent phos-
phorylation of p21 has been shown to be stimulated
by both EGF and insulin (Kamata & Feramisco,
1984). The half-life of the cellular p21 in vitro is of
the order of 20h (Ulsh & Shih, 1984). Widespread
transcription of ras genes has been documented in
embryogenesis (Muller et al., 1983) and increased
transcription is seen in regenerating liver (Goyette
et al., 1984). It is thought therefore that the role of
ras family oncogenes may well be in the control of
cell proliferation, possibly as signal transducers for
growth factors.
Although we have previously demonstrated an
overall elevated expression of ras genes in total
cellular RNA in tissue homogenates from pre-
malignant polyps and malignant carcinomas of the
colerectum relative to normal mucosa it was clearly
impossible to know whether particular cell sub-
populations might have been responsible for the
transcripts present. We have therefore now
attempted to define cell populations of the
colorectum in both normal and pathological states
which contain the translated p21 protein by
immunocytochemical means, using the anti-p21
monoclonal antibody Y13-259 (Furth et al., 1982)
to gain some insight into its involvement in normal
physiology as well as in stages ofcarcinogenesis and
the generation of the malignant phenotype and its
variants.
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Materials and methods
A series of specimens comprising carcinomas (12),
metastatic carcinoma (3), adenomatous polyps (4, -
including one from a case of polyposis coli),
ulcerative colitis, 12-week foetal large bowel and
examples of normal mucosa from both tumour
bearing (5) and disease free patients (2) were
collected and snap frozen in liquid nitrogen.
For immunocytochemistry 5gm frozen sections
were cut and dried overnight. These were then fixed
in acetone for 10min and allowed to dry. Fifty j1 of
antibody at a dilution of 1/100 of our hybridoma
supernatant stock was applied and allowed to
incubate for 2h before being gently washed in Tris-
Saline for 5min. A peroxidase conjugate anti-rat
IgG (Dako) was then applied to the sections for
30min at room temperature followed by a further
5min gentle wash in Tris-Saline. The peroxidase
enzyme was then visualised by immersion in 0.05%
diamino-benzidine (Sigma, London) with hydrogen
peroxide for Omin after which the sections were
washed in water. Sections were counter-stained with
haemotoxylin and then dehydrated, cleared and
mounted.
In order to confirm antibody specificity, over-
night cultures on cover slips of NIH3T3 cells and
SEP14 transformants generated by transfection with
mouse papilloma Ha-ras DNA (Balmain et al.,
1984) were stained as above.
Immunoprecipitation of the ras-p21 species
present in the transfectants was also performed
following metabolic labelling with [35S] methionine
and extraction with lysis buffer (Shih et al., 1980).
The extract was precleared with protein A-
sepharose precoated with rabbit anti-rat immuno-
globulin G and incubated with either the Y13-259
or YA6-172 antibodies. The antigen-antibody
complexes were collected with protein-A-sepharose
precoated rabbit anti-rat immunoglobulin G and
the precipitates were washed and subjected to
electrophoresis on 12.5% polyacrylamide gels
(Laemmli, 1970). Protein bands were identified by
fluorography.
Results
The pattern of immunoperoxidase reactivity seen in
our series is illustrated in Figure 1. It can be seen
that there is a relatively weak but apparently
uniform staining of the epithelial cells in both
normal adult (Figure la-c) and foetal (Figure Id)
colorectal crypts extending from the bases (where
the proliferating stem cells are located) to the
luminal surface. A similar pattern was seen in the
adenomatous polyps (Figure 1f) and carcinomas
(Figure Ig) where some variability in the intensity
of staining within and between tumours was seen,
although this was difficult to reproduce. In both
polyps and carcinomas however, staining did
appear to be more intense, although this was
perhaps partly due to the localisation of the
staining. In both adenomas and carcinomas this
appeared to be clearly cytoplasmic, whilst there was
an impression that in the normal mucosa the
staining was confined more to the cell membrane,
although this was difficult to interpret due to the
presence of intracellular mucin. All cases of tumour
examined exhibited a similar pattern of slightly
variable reactivity which was unrelated to
histological appearance. Samples of mucosa and
polyps from a case of polyposis coli showed a
similar appearance (not shown). The biopsies of a
case of fulminant ulcerative colitis (Figure le) also
showed uniform positive staining regardless of the
degree of epithelial dysplasia. The samples of
metastatic carcinoma examined from liver (Figure
Ih) and lymph node (not shown) again showed
broadly positive staining. Interestingly, however,
the hepatocytes surrounding the metastatic tumour
stained consistently more intensely than the cancer
cells (not shown).
We observed in our series a faint staining of
stromal connective tissue with, however, clear
staining of nerve fibres in the enteric ganglia.
Although bowel wall muscle fibres in the adult do
not stain convincingly those in the section of foetal
large bowel showed marked positivity (Figure ld).
Lymphoid follicles and cells of haematopoietic
lineage occasionally seen in the sections did not
stain at all.
A similar, although less intense, pattern of
staining was seen in our series using the
monoclonal antibody Y6-172 (Furth et al., 1982).
The pattern of staining seen did not differ when
these antibodies were tested over a range of
dilutions from 1/50 to 1/500.
All of our specimens were stained following
frozen section since in our hands reactivity using
acid or neutral formalin-fixed paraffin sections was
not seen, even after trypsinisation.
Specificity of staining was confirmed by the
reactivity of these antibodies with NIH3T3 cells
before, and after (SEP14) transfection with an Ha
ras oncogene. Clear positivity is seen in the
majority of transfectants whereas background levels
of staining only are seen in the 3T3 cells (Figure
2a,b).
Similarly, the results of immunoprecipitation of
the ras p21 contained in the transfectants (Figure 3)
show two bands precipitated by Y13-259 in lane 3.
These correspond to the endogenous Ki-ras p21
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Figure l(a) Normal colonic mucosa. Haematoxylin stained showing typical pattern of endogenous
peroxidase activity, ( x 22). (b) Normal colonic mucosa showing pattern of reactivity with Y13-259 antibody,
(x 22). (c) High power field of Figure l(b), (x 87). (d) Normal foetal large bowel showing pattern of
reactivity with Y13-259 antibody, (x54). (e) Mucosa from a case of fulminant ulcerative colitis showing
pattern of reactivity with Y13-259 antibody, (x 54). (f) Predominantly villous adenoma showing pattern of
reactivity with Y13-259 antibody, ( x 87). (g) Invasive carcinoma of colorectum showing pattern of reactivity
with Y13-259 antibody, (x54). (h) Metastatic carcinoma of colorectum showing pattern of reactivity with
Y13-259 antibody, ( x 87).
Figure 2(a) NIH 3T3 cells showing reactivity with Y13-259 antibody, (x 87). (b) SEP14 cells showing
reactivity with Y13-259 antibody, ( x 87).698 I.B. KERR et al.
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Figure 3 Immunoprecipitation of p21 ras proteins
from SEP14 transfectants with YAG172 (lane 1),
normal rat serum (lane 2) and Y13'-259 (lane 3).
Arrows indicate p21 species (see text). Bars indicate the
relative mobilities of marker proteins of molecular
weights 25.7 KD and 18.4KD.
(faster mobility). YA6-172 precipitates only Ha-ras
p21 in mouse cells as shown by the single band in
lane 1.
Discussion
On the basis of available evidence activity of
cellular ras proto-oncogenes has hitherto been
putatively associated with cell growth and pro-
liferation and, in an activated oncogenic form, with
carcinogenesis (Balmain, 1985). Our results,
however, suggest that production of the p21 ras
encoded protein as detected by the monoclonal
antibody Y13-259 is not restricted to cells which are
actively growing or dividing, either in normal
mucosa or in tumours where, although identifi-
cation of clonogenic tumour stem cells is much less
easy, the fact that their growth fraction is only in
the region of 15% (Wright, 1984) indicates that the
pattern of staining observed cannot be ascribed to
them alone. In normal crypts the epithelial cell
survival time is of the order of 4-8 days (Wright,
1984) whereas the results of in vitro experiments
suggest that the half-life of the c-Ha-ras p21 is only
20h, (Ulsh & Shih, 1984) although this may not
be the case in vivo.
Although both benign and malignant tumours
appear to stain rather more intensely than normal
mucosa it is difficult to interpret the biological
significance of this due to the virtual 'all or
nothing' nature of such immunocytochemical
reactivity, which effectively precludes meaningful
quantitation of staining, (see Docherty, 1984). In
addition, these antibodies appear to react relatively
weakly with tissue sections.
Nonetheless it appears that the immunological
demonstration of the ras encoded p21 protein does
not differentially identify particular subpopulations
of cells either involved in cell proliferation nor any
present in specimens of adenomas or ulcerative
colitis, both recognised to be premalignant con-
ditions (see Morson & Dawson, 1979), which might
have particular malignant potential. Similarly, sub-
populations of cancer cells which may have, for
example, an increased metastatic potential
obviously can not be identified by these techniques.
We have previously shown elevated levels of ras
family oncogene expression in premalignant and
malignant tumours of the colorectum and suggested
that elevated expression of ras genes may be critical
in the process of carcinogenesis but not in itself
sufficient. Our present results are certainly not
inconsistent with such an interpretation. These
suggest, however, that immunocytochemical study
of p21 distribution with this antibody will
contribute little to a more accurate assessment of
stages of carcinogenesis or of variations of the
malignant phenotype. It is of course the case that
expression of variously mutated p21's in a cell
population or sub-population which might be
significant would not be detected using this
particular antibody (which reacts broadly with both
Ha- and Ki-ras p21 products) and the development
of antibodies directed to particular mutated
epitopes would be required to define them.
Similarly the significance of the apparent
cytoplasmic localisation of the p21 in tumours
when the normal p21 is reported as being
membrane-associated (Willingham et al., 1980) is
not clear, and its interpretation will await the
results of ultrastructural study which we are
currently undertaking.
During the course of this study reports have
appeared of the reactivity of a further series of anti
p21 antibodies (RAP 1-5) raised against synthetic
ras peptides corresponding to the region around
codon 12, with formalin-fixed paraffin-processed
sections of breast (Hand et al., 1984) and colon
(Thor et al., 1984) carcinomas. These showed a
heterogeneous pattern of staining, which was seen,
however, in only a few benign lesions and not inIMMUNOCYTOCHEMICAL DEFECTION OF RAS p21 ONCOPROTEIN 699
normal epithelium. Reactivity with cryostat sections
was not reported. It was therefore suggested that
such reactivity may be a useful marker of stages of
carcinogenesis.
The reason for the discrepancies in reactivity seen
is not at all clear since neither the Y13-259 nor
RAP 1-5 antibodies can distinguish normal from
mutated p21 immunocytochemically. It is possible
that there may be selective presentation of the
epitope recognised by the RAP antibodies in
associated with malignant transformation. Alterna-
tively, the heterogenous reactivity seen with these
antibodies may represent a quantitative
phenomenon with lesser amounts of antigen not
being seen due to loss of antigen in processing, a
phenomenon well-recognised in immuno-
cytochemistry (see Polak & van Noorden, 1983).
Indeed in our previous studies we observed elevated
levels of ras RNA transcription in a series of
colorectal carcinomas relative to normal mucosa
(Spandidos & Kerr, 1984) which would be
consistent with such a hypothesis. In that study
however, even higher levels of RNA transcription
were seen in several adenomata which appear to
show minimal reactivity with the RAP antibodies.
Our present results, in any case, seem to suggest
that production of at least some p21 is a feature of
normal cellular metabolism in certain cell types and
that reactivity with the Y13-259 antibody is not
helpful in defining either cells at different stages of
carcinogenesis nor those representing variants of a
malignant phenotype.
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